Related Experiment Video
Updated: Jun 20, 2026
09:44
Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Crohn's Disease Enteritis: Pathophysiological Mechanisms and Therapeutic Approaches
1Xinjiang Agricultural University, Urumqi, Xinjiang, China.
Scandinavian Journal of Immunology
|June 19, 2026
Summary
Crohn's disease involves complex interactions between genetics, immunity, and the gut microbiome. Understanding these factors is key to developing personalized treatments for this chronic inflammatory condition.
Area of Science:
- Gastroenterology and Immunology
- Chronic Inflammatory Diseases
- Gut Microbiome Research
Background:
- Crohn's disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract.
- Pathogenesis involves genetic susceptibility, immune dysregulation, gut microbiota, and environmental factors.
- Key pathways include T-helper 1 (Th1) and T-helper 17 (Th17) signalling, with central roles for cytokines like TNF-α and IL-17.
Purpose of the Study:
- To provide a comprehensive review of Crohn's disease pathophysiology.
- To highlight advancements in diagnostics and therapeutics.
- To discuss challenges and future directions in CD management.
Main Methods:
- Review of existing literature on Crohn's disease.
- Analysis of genetic, immunological, and microbiological data.
- Evaluation of advanced models (organoids, xenografts) and diagnostic tools (capsule endoscopy, MRI, faecal calprotectin).
Main Results:
- CD pathogenesis is driven by interplay of epithelial cells, immune responses, microbiota, and triggers.
- Genetic factors (NOD2, ATG16L1, IL23R) and cytokine networks (TNF-α, IL-6, IL-17) are crucial.
- Diagnostic tools enable precise phenotyping; therapies include biologics and JAK inhibitors.
Conclusions:
- Despite progress, refractory CD and complications remain challenging.
- Personalized medicine, integrating immunological, microbiota, and molecular data, is promising.
- Integrated, personalized strategies are essential for improving patient outcomes in Crohn's disease.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...